Ewborn 2 days later. and the patient was discharged collectively with together with and postnatal uneventful, newborn 2 days newborn two days later. gether with her later.Medicina 2021, 57, x FOR PEER Evaluation Medicina 2021, 57, 1207 Medicina 2021, 57, x FOR PEER REVIEW55 of eight of eight five ofFigure 7. Left cornu with the uterus visualized by transabdominal ultrasonography 1 day postparFigure 7. Left cornu the uterus visualized by transabdominal ultrasonography 1 day postpartum. Figure 7. Left cornu ofof the uterus visualized by transabdominal ultrasonography 1 day postpartum. tum.After the discharge, follow-up visits were Decanoyl-L-carnitine Data Sheet arranged in an outpatient clinic. The Soon after the discharge, follow-up visits had been arranged in an outpatient clinic. The furfurther postpartum period was uneventful, along with the patient did not have any precise Right after the discharge, follow-up visits have been arranged in an outpatient clinic. The further postpartum period was uneventful, as well as the patient didn’t have any specific comcomplaints. The human chorionic gonadotropin (-hCG) bloodhave any precise comther postpartum period was uneventful, as well as the patient did not tests had been performed plaints. The human chorionic gonadotropin (-hCG) blood tests were performed on the on the 1st, 7th, human chorionic gonadotropin (-hCG) bloodittests have been performed on the plaints. The 14th and 30th days immediately after PF-06873600 manufacturer delivery–in 30 days decreased drastically from 1st, 7th, 14th and 30th days following delivery–in 30 days it decreased drastically from 3602 36027th, 14th and 30th daysliter (IU/L) to 1.78 IU/L accordingly. Table 1 1st, international units per just after delivery–in 30 days it decreased drastically from 3602 international units per liter (IU/L) to 1.78 IU/L accordingly. Table 1 international units per liter (IU/L) to 1.78 IU/L accordingly. TableTable 1. Patient’s human chorionic gonadotropin (-hCG) levels postpartum. Table 1. Patient’s human chorionic gonadotropin (-hCG) levels postpartum. Table 1. Patient’s human chorionic gonadotropin (-hCG) levels postpartum. Days Postpartum 1 7 14Days Postpartum Days Postpartum -hCG (IU/L) -hCG (IU/L) -hCG (IU/L)1 1 3602 36027 7 59.4 59.4 59.14 14 4.82 4.82 four.1.30 1.78 1.The follow-up transvaginal ultrasonography was performed following one particular month. The The follow-up transvaginal ultrasonography was performed soon after 1 month. The The follow-up transvaginal ultrasonography was much more intensive blood flow was remaining mass sized 1.67 0.56 cm with visually far more intensive blood flow wasThe 1.67 0.56 cm with visually performed right after 1 month. obremaining mass remainingFigure eight. mass sized 1.67 0.56 cm with visually additional intensive blood flow was obobserved. served. Figure 8. served. Figure 8.Figure 8. Left cornu of your uterus visualized by transvaginal ultrasonography 30 days postpartum. Figure 8. Left cornu of your uterus visualized by transvaginal ultrasonography 30 days postpartum. Figure 8. Left cornu in the uterus visualized by transvaginal ultrasonography 30 days postpartum.three. Discussion 3. Discussion 3. Discussion Heterotopic pregnancy is aarare, difficult to diagnose and life-threatening pathology Heterotopic pregnancy is uncommon, challenging to diagnose and life-threatening pathology Heterotopic pregnancy is rare, life-threatening pathology and its incidence tends to growa duetodifficult to diagnose and pregnancies following assisted and its incidence tends to growdue toan improved quantity of pregnancies just after assisted an elevated quantity of and its incidence tends toand ovulatio.